Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease.

Puleston J, Cooper M, Murch S, Bid K, Makh S, Ashwood P, Bingham AH, Green H, Moss P, Dhillon A, Morris R, Strobel S, Gelinas R, Pounder RE, Platt A.

Aliment Pharmacol Ther. 2005 Jan 15;21(2):109-20.

2.

Medical outpatients: changes that can benefit patients.

Dunnill MG, Pounder RE.

Clin Med (Lond). 2004 Jan-Feb;4(1):45-9. Review.

3.

Prevalence of gastrointestinal diseases in two British national birth cohorts.

Ehlin AG, Montgomery SM, Ekbom A, Pounder RE, Wakefield AJ.

Gut. 2003 Aug;52(8):1117-21.

4.

Eradication of Helicobacter pylori increases nocturnal intragastric acidity during dosing with rabeprazole, omeprazole, lansoprazole and placebo.

Williams MP, Usselmann B, Chilton A, Sercombe J, Nwokolo CU, Pounder RE.

Aliment Pharmacol Ther. 2003 Mar 15;17(6):775-83.

5.

Siblings and the risk of inflammatory bowel disease.

Montgomery SM, Lambe M, Wakefield AJ, Pounder RE, Ekbom A.

Scand J Gastroenterol. 2002 Nov;37(11):1301-8.

PMID:
12465729
6.

Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer.

Brett BT, Smith SC, Bouvier CV, Michaeli D, Hochhauser D, Davidson BR, Kurzawinski TR, Watkinson AF, Van Someren N, Pounder RE, Caplin ME.

J Clin Oncol. 2002 Oct 15;20(20):4225-31.

PMID:
12377966
7.

A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin.

Gordon FH, Hamilton MI, Donoghue S, Greenlees C, Palmer T, Rowley-Jones D, Dhillon AP, Amlot PL, Pounder RE.

Aliment Pharmacol Ther. 2002 Apr;16(4):699-705.

8.
9.

Helicobacter pylori and NSAIDs--the end of the debate?

Pounder RE.

Lancet. 2002 Jan 5;359(9300):3-4. No abstract available.

PMID:
11809174
10.

Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.

Hamilton MI, Sercombe J, Pounder RE.

Aliment Pharmacol Ther. 2001 Oct;15(10):1579-83.

11.

A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease.

Gordon FH, Lai CW, Hamilton MI, Allison MC, Srivastava ED, Fouweather MG, Donoghue S, Greenlees C, Subhani J, Amlot PL, Pounder RE.

Gastroenterology. 2001 Aug;121(2):268-74.

PMID:
11487536
12.

Inflammatory bowel disease and laterality: is left handedness a risk?

Morris DL, Montgomery SM, Galloway ML, Pounder RE, Wakefield AJ.

Gut. 2001 Aug;49(2):199-202.

13.

Asian ethnic origin and the risk of inflammatory bowel disease.

Montgomery SM, Morris DL, Pounder RE, Wakefield AJ.

Eur J Gastroenterol Hepatol. 1999 May;11(5):543-6.

PMID:
10755259
14.

Measles vaccination and inflammatory bowel disease: a national British Cohort Study.

Morris DL, Montgomery SM, Thompson NP, Ebrahim S, Pounder RE, Wakefield AJ.

Am J Gastroenterol. 2000 Dec;95(12):3507-12.

PMID:
11151885
15.

The initial care of newborn infants and subsequent hay fever.

Montgomery SM, Wakefield AJ, Morris DL, Pounder RE, Murch SH.

Allergy. 2000 Oct;55(10):916-22.

PMID:
11030371
16.
17.

Beta(beta)3-adrenergic receptors in human pancreatic islet and duodenal somatostatin neuroendocrine cells.

Anthony A, Sim R, Guillaume JL, Strosberg AD, Dhillon AP, Pounder RE, Wakefield AJ.

Aliment Pharmacol Ther. 2000 May;14(5):579-85.

18.

Endothelial changes precede mucosal ulceration induced by indomethacin: an experimental study in the rat.

Kelly D, Anthony A, Piasecki C, Lewin J, Pounder RE, Wakefield AJ.

Aliment Pharmacol Ther. 2000 Apr;14(4):489-96.

19.

Eradication of Helicobacter pylori and non-ulcer dyspepsia.

Danesh J, Pounder RE.

Lancet. 2000 Mar 4;355(9206):766-7. No abstract available.

PMID:
10711918
20.

Early determinants of inflammatory bowel disease: use of two national longitudinal birth cohorts.

Thompson NP, Montgomery SM, Wadsworth ME, Pounder RE, Wakefield AJ.

Eur J Gastroenterol Hepatol. 2000 Jan;12(1):25-30.

PMID:
10656206
21.

Similarities between ileal Crohn's disease and indomethacin experimental jejunal ulcers in the rat.

Anthony A, Pounder RE, Dhillon AP, Wakefield AJ.

Aliment Pharmacol Ther. 2000 Feb;14(2):241-5.

22.

Omeprazole and accelerated onset of atrophic gastritis.

Pounder RE, Williams MP.

Gastroenterology. 2000 Jan;118(1):238-9. No abstract available.

PMID:
10644180
23.
24.

Helicobacter pylori: from the benign to the malignant.

Williams MP, Pounder RE.

Am J Gastroenterol. 1999 Nov;94(11 Suppl):S11-6. Review.

PMID:
10565604
25.

Demonstration of new sites of expression of the CCK-B/gastrin receptor in pancreatic acinar AR42J cells using immunoelectron microscopy.

Caplin ME, Clarke P, Grimes S, Dhillon AP, Khan K, Savage K, Lewin J, Michaeli D, Pounder RE, Watson SA.

Regul Pept. 1999 Oct 22;84(1-3):81-9.

PMID:
10535412
26.

Review article: the pharmacology of rabeprazole.

Williams MP, Pounder RE.

Aliment Pharmacol Ther. 1999 Aug;13 Suppl 3:3-10. Review.

27.

Laser assisted ratio analyser 13C-urea breath testing, for the detection of H. pylori: A prospective diagnostic European multicentre study.

Van Der Hulst RW, Lamouliatte H, Megraud F, Pounder RE, Stolte M, Vaira D, Williams M, Tytgat GN.

Aliment Pharmacol Ther. 1999 Sep;13(9):1171-7.

28.

The effect of omeprazole dosing on the isolation of Helicobacter pylori from gastric aspirates.

Williams MP, Sercombe JC, Lawson AJ, Slater E, Owen RJ, Pounder RE.

Aliment Pharmacol Ther. 1999 Sep;13(9):1161-9.

29.

Crohn's disease: the case for measles virus.

Wakefield AJ, Montgomery SM, Pounder RE.

Ital J Gastroenterol Hepatol. 1999 Apr;31(3):247-54. Review.

PMID:
10379489
30.

Soil exposure no protection against atopy.

Montgomery SM, Twamley SI, Murch SH, Pounder RE, Wakefield AJ.

Immunol Today. 1999 Jun;20(6):289-90. No abstract available.

PMID:
10354631
31.

The colonic mesenteric margin is most susceptible to injury in an experimental model of colonic ulceration.

Anthony A, Dhillon AP, Pounder RE, Wakefield AJ.

Aliment Pharmacol Ther. 1999 Apr;13(4):531-5.

32.

Paramyxovirus infections in childhood and subsequent inflammatory bowel disease.

Montgomery SM, Morris DL, Pounder RE, Wakefield AJ.

Gastroenterology. 1999 Apr;116(4):796-803.

PMID:
10092301
33.

Smoking in adults and passive smoking in children are associated with acute appendicitis.

Montgomery SM, Pounder RE, Wakefield AJ.

Lancet. 1999 Jan 30;353(9150):379. No abstract available.

PMID:
9950450
34.

Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues.

Walmsley RS, Anthony A, Sim R, Pounder RE, Wakefield AJ.

J Clin Pathol. 1998 Sep;51(9):657-61.

35.

Patients consulting with Crohn's disease in primary care in England and Wales.

Thompson NP, Fleming DM, Charlton J, Pounder RE, Wakefield AJ.

Eur J Gastroenterol Hepatol. 1998 Dec;10(12):1007-12.

PMID:
9895046
36.

Reversal and protection against indomethacin-induced blood stasis and mucosal damage in the rat jejunum by a beta3-adrenoceptor agonist.

Kelly D, Piasecki C, Anthony A, Dhillon AP, Pounder RE, Wakefield AJ.

Aliment Pharmacol Ther. 1998 Nov;12(11):1121-9.

38.

Comparison of three RNA amplification methods as sources of DNA for sequencing.

Chadwick N, Wakefield AJ, Pounder RE, Bruce IJ.

Biotechniques. 1998 Nov;25(5):818-20, 822.

39.

Measles IgM immunoreactivity in patients with inflammatory bowel disease.

Balzola FA, Khan K, Pera A, Bonino F, Pounder RE, Wakefield AJ.

Ital J Gastroenterol Hepatol. 1998 Aug;30(4):378-82.

PMID:
9789132
40.

A simple clinical colitis activity index.

Walmsley RS, Ayres RC, Pounder RE, Allan RN.

Gut. 1998 Jul;43(1):29-32.

41.

Localization of the beta(beta)3-adrenoceptor in the human gastrointestinal tract: an immunohistochemical study.

Anthony A, Schepelmann S, Guillaume JL, Strosberg AD, Dhillon AP, Pounder RE, Wakefield AJ.

Aliment Pharmacol Ther. 1998 Jun;12(6):519-25.

42.
43.
44.

Focal reduction of villous blood flow in early indomethacin enteropathy: a dynamic vascular study in the rat.

Kelly DA, Piasecki C, Anthony A, Dhillon AP, Pounder RE, Wakefield AJ.

Gut. 1998 Mar;42(3):366-73.

45.

The effects of low doses of ranitidine on intragastric acidity in healthy men.

Wyeth JW, Pounder RE, Sercombe JC, Snell CC.

Aliment Pharmacol Ther. 1998 Mar;12(3):255-61.

46.

Prevalence of inflammatory bowel disease in British 26 year olds: national longitudinal birth cohort.

Montgomery SM, Morris DL, Thompson NP, Subhani J, Pounder RE, Wakefield AJ.

BMJ. 1998 Apr 4;316(7137):1058-9. No abstract available.

47.

Ulceration of the ileum in Crohn's disease: correlation with vascular anatomy.

Anthony A, Dhillon AP, Pounder RE, Wakefield AJ.

J Clin Pathol. 1997 Dec;50(12):1013-7.

48.

Vascular anatomy defines sites of indomethacin induced jejunal ulceration along the mesenteric margin.

Anthony A, Pounder RE, Dhillon AP, Wakefield AJ.

Gut. 1997 Dec;41(6):763-70.

49.

Ranitidine bismuth citrate with clarithromycin for the eradication of Helicobacter pylori and for ulcer healing.

Pounder RE, Wyeth JW, Duggan AE, Bailey RJ, Louw JA, Ohlin B.

Helicobacter. 1997 Sep;2(3):132-9.

PMID:
9432341
50.

Measles vaccination and inflammatory bowel disease.

Montgomery SM, Morris DL, Pounder RE, Wakefield AJ.

Lancet. 1997 Dec 13;350(9093):1774. No abstract available.

PMID:
9413482

Supplemental Content

Loading ...
Support Center